Twist Bioscience Appoints Adam Laponis as Chief Financial Officer

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced the appointment of Adam Laponis as chief financial officer. Mr. Laponis brings experience across small cap and Fortune 50 companies along with a track record of collaborating across teams to drive profitable growth. “Adam’s… Continue reading Twist Bioscience Appoints Adam Laponis as Chief Financial Officer

DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced the appointment of Susan Tousi as Chief Executive Officer. Ms. Tousi joins DELFI from Illumina, Inc. where she held multiple leadership roles during a more than 10-year tenure, most recently as Chief Commercial Officer leading global sales, service… Continue reading DELFI Diagnostics Appoints Susan Tousi as New Chief Executive Officer

Calliditas Therapeutics appoints Maria Törnsén as President North America

Calliditas Therapeutics AB, a commercial biopharma company focused on rare diseases, announced that Maria Törnsén has been appointed to the position of President North America. Ms Törnsén will be responsible for all US based operations and will report to the CEO. Maria Törnsén has broad commercial leadership experience having spent more than 20 years in the… Continue reading Calliditas Therapeutics appoints Maria Törnsén as President North America

ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen

ATCC, the world’s premier biological materials management and standards organization, announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures to protect Americans from public… Continue reading ATCC Announces New Award from BARDA to Provide Centralized Storage and Bioprocessing Services for Project NextGen

AGCO Names Viren Shah as Chief Digital & Information Officer

AGCO, a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, announced the addition of a Chief Digital & Information Officer (CDIO) to its senior leadership team, reporting directly to Chief Executive Officer Eric Hansotia. Viren Shah will become an AGCO Senior Vice President and CDIO effective January 16,… Continue reading AGCO Names Viren Shah as Chief Digital & Information Officer

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

Better Therapeutics Inc., a pioneer in developing prescription digital therapeutics for treating cardiometabolic diseases, and Glooko, Inc., a global leader in chronic condition management, announced a partnership to integrate Better Therapeutics’ AspyreRx digital behavioral treatment for type 2 diabetes (T2D) into Glooko’s diabetes management platform. This collaboration will enable healthcare providers in the United States who… Continue reading Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States

Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life sciences industry, he brings a unique combination of scientific innovation and strategic business development to the company. His experience in driving organizational transformation and large-scale… Continue reading Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Immunome Appoints Phil Roberts as Chief Technical Officer

Immunome, Inc., a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced the appointment of Phil Roberts as Chief Technical Officer. Mr. Roberts has over three decades of experience in product development, global manufacturing, and commercialization of novel pharmaceutical products. “Immunome is delighted to add Phil to our management team as we… Continue reading Immunome Appoints Phil Roberts as Chief Technical Officer

X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer

X-Chem, the leading provider of innovative solutions in early-stage drug discovery, announced executive management team changes aimed at expanding its position as a premium provider of integrated services to drug hunters. Karen Lackey, currently Chief Scientific Officer, will transition to the role of Chief Executive Officer. Karen’s extensive drug discovery experience in both pharma and… Continue reading X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer

NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical Officer

NiKang Therapeutics Inc., a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced the appointment of Joanne (Jo) Lager, M.D., as Chief Medical Officer (CMO), reporting to Zhenhai Gao, Ph.D., Co-founder, President and Chief Executive Officer (CEO) of NiKang. As a member of the… Continue reading NiKang Therapeutics Appoints Joanne Lager, M.D., as Chief Medical Officer